[1] Jemal A, Siegel R, Xu JQ, et al.  Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.   doi: 10.3322/caac.20073
[2] Solbiati L, Cioffi V, Ballarati E.  Ultrasonography of the neck[J]. Radiol Clin North Am, 1992, 30(5): 941-954.
[3] 陈晓辉, 柳硕岩, 吴周贵.  彩超检查对食管癌颈部淋巴结转移的诊断价值(附150例分析)[J]. 福建医药杂志, 2009, 31(3): 108-110.   doi: 10.3969/j.issn.1002-2600.2009.03.065
[4] 于海容, 朱强, 乔华.  超声对头颈部恶性肿瘤颈部淋巴结转移的诊断价值[J]. 山东医药, 2009, 49(48): 77-79.   doi: 10.3969/j.issn.1002-266X.2009.48.038
[5] Rubaltelli L, Corradin S, Dorigo A, et al.  Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography[J]. AJR Am J Roentgenol, 2007, 188(4): 977-983.   doi: 10.2214/AJR.06.0562
[6] Valls C, Andía E, Sanchez A, et al.  Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery[J]. AJR Am J Roentgenol, 2002, 178(4): 821-826.   doi: 10.2214/ajr.178.4.1780821
[7] 陆秀伟, 谢筱晞, 徐莉萍, 等.  胆囊癌淋巴结转移的多层螺旋CT分析[J]. 实用放射学杂志, 2010, 26(9): 1295-1297.   doi: 10.3969/j.issn.1002-1671.2010.09.018
[8] 乔英, 李健丁, 张瑞平, 等.  CT三期增强扫描对胃癌淋巴结转移的诊断价值[J]. 放射学实践, 2006, 21(5): 507-510.   doi: 10.3969/j.issn.1000-0313.2006.05.021
[9] Rumboldt Z, Al-Okaili R, Deveikis JP.  Perfusion CT for head and neck tumors: pilot study[J]. AJNR Am J Neuroradiol, 2005, 26(5): 1178-1185.
[10] de Bondt RB, Hoeberigs MC, Nelemans PJ, et al.  Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma[J]. Neuroradiology, 2009, 51(3): 183-192.   doi: 10.1007/s00234-008-0487-2
[11] Eiber M, Beer AJ, Holzapfel K, et al.  Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging[J]. Invest Radiol, 2010, 45(1): 15-23.   doi: 10.1097/RLI.0b013e3181bbdc2f
[12] Nakai G, Matsuki M, Inada Y, et al.  Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging[J]. J Comput Assist Tomogr, 2008, 32(5): 764-768.   doi: 10.1097/RCT.0b013e318153fd43
[13] Kwee TC, Takahara T, Luijten PR, et al.  ADC measurements of lymph nodes: inter-and intra-observer reproducibility study and an overview of the literature[J]. Eur J Radiol, 2010, 75(2): 215-220.   doi: 10.1016/j.ejrad.2009.03.026
[14] Saokar A, Braschi M, Harisinghani M.  Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging[J]. Abdom Imaging, 2006, 31(6): 660-667.   doi: 10.1007/s00261-006-9006-2
[15] Harisinghani MG, Saini S, Weissleder R, et al.  MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation[J]. AJR Am J Roentgenol, 1999, 172(5): 1347-1351.   doi: 10.2214/ajr.172.5.10227514
[16] 吴元魁, 许乙凯, 黄其鎏.  超顺磁氧化铁粒子增强MRI区分肿瘤转移性与良性淋巴结的实验研究[J]. 中华放射学杂志, 2002, 36(6): 562-566.   doi: 10.3760/j.issn:1005-1201.2002.06.022
[17] Pandharipande PV, Mora JT, Uppot RN, et al.  Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model[J]. AJR Am J Roentgenol, 2009, 193(3): W230-W237.   doi: 10.2214/AJR.08.2175
[18] Will O, Purkayastha S, Chan C, et al.  Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a metaanalysis[J]. Lancet Oncol, 2006, 7(1): 52-60.   doi: 10.1016/S1470-2045(05)70537-4
[19] Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al.  Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients[J]. Eur Urol, 2009, 55(4): 761-769.   doi: 10.1016/j.eururo.2008.12.034
[20] Fletcher JW, Djulbegovic B, Soares HP, et al.  Recommendations on the use of 18F-FDG PET in oncology[J]. J Nucl Med, 2008, 49(3): 480-508.   doi: 10.2967/jnumed.107.047787
[21] Kyzas PA, Evangelou E, Denaxa-Kyza D, et al.  18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a metaanalysis[J]. J Natl Cancer Inst, 2008, 100(10): 712-720.   doi: 10.1093/jnci/djn125
[22] Gould MK, Kuschner WG, Rydzak CE, et al.  Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis[J]. Ann Intern Med, 2003, 139(11): 879-892.   doi: 10.7326/0003-4819-139-11-200311180-00013
[23] Basu S, Kung J, Houseni M, et al.  Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions[J]. Q J Nucl Med Mol Imaging, 2009, 53(1): 9-19.
[24] Kwee TC, Basu S, Torigian DA, et al.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting[J]. Eur J Nucl Med Mol Imaging, 2011, 38(7): 1353-1366.   doi: 10.1007/s00259-010-1717-5
[25] Jeong HS, Baek CH, Son YI, et al.  Use of integrated 18F-FDG PET/ CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma[J]. Head Neck, 2007, 29(3): 203-210.   doi: 10.1002/hed.20504